Limited utility of RECIST 1.1 in predicting pathologic response to neoadjuvant radiotherapy in myxoid liposarcoma

Yuri Velichko et al.

RSNA 2024

BibTeX

Cite this work

Yuri Velichko et al. (2024). Limited utility of RECIST 1.1 in predicting pathologic response to neoadjuvant radiotherapy in myxoid liposarcoma. RSNA 2024

BibTeX